Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiotherapy Planning, Computer-Assisted | 17 | 2022 | 176 | 4.730 |
Why?
|
Radiotherapy, Intensity-Modulated | 12 | 2022 | 173 | 2.850 |
Why?
|
Monte Carlo Method | 14 | 2020 | 185 | 2.850 |
Why?
|
Brachytherapy | 6 | 2020 | 119 | 1.680 |
Why?
|
Photons | 5 | 2016 | 46 | 1.440 |
Why?
|
Phantoms, Imaging | 12 | 2023 | 429 | 1.420 |
Why?
|
Head and Neck Neoplasms | 9 | 2022 | 1052 | 1.360 |
Why?
|
Models, Theoretical | 4 | 2019 | 482 | 1.270 |
Why?
|
Radiotherapy Dosage | 13 | 2022 | 468 | 1.230 |
Why?
|
Computer-Aided Design | 2 | 2015 | 18 | 1.050 |
Why?
|
Radiation Dosage | 4 | 2013 | 227 | 0.960 |
Why?
|
Four-Dimensional Computed Tomography | 4 | 2021 | 18 | 0.910 |
Why?
|
Electrons | 4 | 2017 | 49 | 0.900 |
Why?
|
Algorithms | 12 | 2022 | 1830 | 0.860 |
Why?
|
Particle Accelerators | 3 | 2017 | 16 | 0.820 |
Why?
|
Water | 3 | 2017 | 277 | 0.770 |
Why?
|
Radiosurgery | 2 | 2020 | 272 | 0.730 |
Why?
|
Computer Graphics | 4 | 2020 | 100 | 0.720 |
Why?
|
Rectovaginal Fistula | 1 | 2019 | 7 | 0.700 |
Why?
|
Support Vector Machine | 1 | 2019 | 25 | 0.700 |
Why?
|
Vesicovaginal Fistula | 1 | 2019 | 12 | 0.690 |
Why?
|
Prostatic Neoplasms | 8 | 2020 | 1721 | 0.670 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 107 | 0.630 |
Why?
|
Image Processing, Computer-Assisted | 7 | 2022 | 1204 | 0.590 |
Why?
|
Protons | 1 | 2017 | 98 | 0.580 |
Why?
|
Patient Care Planning | 1 | 2017 | 81 | 0.580 |
Why?
|
Software | 3 | 2016 | 654 | 0.540 |
Why?
|
Cone-Beam Computed Tomography | 5 | 2023 | 64 | 0.460 |
Why?
|
Lung Neoplasms | 5 | 2023 | 2262 | 0.410 |
Why?
|
Radiation Protection | 1 | 2011 | 25 | 0.410 |
Why?
|
DNA | 1 | 2017 | 1294 | 0.390 |
Why?
|
Radiotherapy, Image-Guided | 3 | 2020 | 56 | 0.360 |
Why?
|
Radiation, Ionizing | 2 | 2020 | 121 | 0.360 |
Why?
|
Tomography, X-Ray Computed | 4 | 2022 | 2601 | 0.330 |
Why?
|
Computer Simulation | 4 | 2020 | 1078 | 0.330 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2011 | 466 | 0.320 |
Why?
|
DNA Damage | 2 | 2020 | 366 | 0.320 |
Why?
|
Heavy Ion Radiotherapy | 2 | 2017 | 2 | 0.310 |
Why?
|
Computers | 2 | 2016 | 112 | 0.290 |
Why?
|
Radiometry | 2 | 2016 | 53 | 0.270 |
Why?
|
Humans | 29 | 2023 | 86643 | 0.250 |
Why?
|
Needles | 2 | 2020 | 35 | 0.240 |
Why?
|
Automation | 3 | 2020 | 106 | 0.200 |
Why?
|
Proof of Concept Study | 1 | 2020 | 38 | 0.190 |
Why?
|
Supervised Machine Learning | 1 | 2020 | 8 | 0.190 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 3362 | 0.180 |
Why?
|
Glioma | 1 | 2022 | 285 | 0.180 |
Why?
|
Uncertainty | 1 | 2020 | 71 | 0.180 |
Why?
|
Rectum | 1 | 2020 | 146 | 0.170 |
Why?
|
Imaging, Three-Dimensional | 2 | 2020 | 579 | 0.170 |
Why?
|
Area Under Curve | 1 | 2019 | 334 | 0.160 |
Why?
|
Movement | 1 | 2020 | 299 | 0.160 |
Why?
|
Proton Therapy | 1 | 2016 | 27 | 0.150 |
Why?
|
Brain Neoplasms | 1 | 2022 | 763 | 0.140 |
Why?
|
Anisotropy | 1 | 2016 | 62 | 0.140 |
Why?
|
Prostate | 1 | 2019 | 378 | 0.140 |
Why?
|
Time Factors | 3 | 2015 | 5210 | 0.140 |
Why?
|
Quality Control | 1 | 2015 | 117 | 0.130 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 120 | 0.130 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 1673 | 0.120 |
Why?
|
Male | 9 | 2020 | 40965 | 0.120 |
Why?
|
Radiotherapy, Computer-Assisted | 1 | 2013 | 25 | 0.120 |
Why?
|
Ultrasonography | 3 | 2020 | 695 | 0.120 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1075 | 0.120 |
Why?
|
Artifacts | 2 | 2012 | 244 | 0.110 |
Why?
|
Safety | 1 | 2011 | 152 | 0.100 |
Why?
|
Retrospective Studies | 2 | 2021 | 8489 | 0.090 |
Why?
|
Radiography, Thoracic | 1 | 2011 | 320 | 0.080 |
Why?
|
Risk Factors | 1 | 2019 | 5417 | 0.080 |
Why?
|
Aged, 80 and over | 1 | 2019 | 6509 | 0.080 |
Why?
|
Lymphocytes | 2 | 2020 | 464 | 0.080 |
Why?
|
Organs at Risk | 2 | 2017 | 41 | 0.070 |
Why?
|
Lung | 2 | 2023 | 1170 | 0.070 |
Why?
|
Aged | 1 | 2019 | 18415 | 0.050 |
Why?
|
Motion | 1 | 2021 | 85 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2020 | 2705 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2023 | 751 | 0.050 |
Why?
|
Tumor Burden | 1 | 2021 | 289 | 0.050 |
Why?
|
Middle Aged | 1 | 2019 | 25028 | 0.050 |
Why?
|
Adult | 1 | 2019 | 25648 | 0.050 |
Why?
|
Respiration | 1 | 2020 | 262 | 0.040 |
Why?
|
Relative Biological Effectiveness | 1 | 2017 | 13 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2020 | 579 | 0.040 |
Why?
|
Organ Sparing Treatments | 1 | 2017 | 38 | 0.040 |
Why?
|
Carbon Radioisotopes | 1 | 2017 | 35 | 0.040 |
Why?
|
Chromatin | 1 | 2020 | 380 | 0.040 |
Why?
|
User-Computer Interface | 1 | 2017 | 185 | 0.040 |
Why?
|
Linear Models | 1 | 2017 | 421 | 0.040 |
Why?
|
Scattering, Radiation | 1 | 2016 | 114 | 0.030 |
Why?
|
Female | 1 | 2019 | 44532 | 0.030 |
Why?
|
Retreatment | 1 | 2014 | 107 | 0.030 |
Why?
|
Organ Size | 1 | 2013 | 364 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2017 | 645 | 0.030 |
Why?
|
Models, Statistical | 1 | 2015 | 574 | 0.020 |
Why?
|
Child | 1 | 2021 | 6927 | 0.020 |
Why?
|